{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:54:31Z","timestamp":1793764471271,"version":"4.6.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.amjcard.2016.07.054","type":"journal-article","created":{"date-parts":[[2016,8,14]],"date-time":"2016-08-14T18:46:15Z","timestamp":1471200375000},"page":"1275-1281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials)"],"prefix":"10.1016","volume":"118","author":[{"given":"Payal","family":"Kohli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-7240","authenticated-orcid":false,"given":"Joshua W.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Sarraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Reaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2016.07.054_bib1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2016.07.054_bib2","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2016.07.054_bib3","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jacc.2010.10.047","article-title":"Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials","volume":"57","author":"Waters","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.07.054_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2012.06.001","article-title":"Statins are diabetogenic\u2014myth or reality?","volume":"13","author":"Sattar","year":"2012","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.amjcard.2016.07.054_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2016.07.054_bib6","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.amjcard.2016.07.054_bib7","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1056\/NEJM199312303292703","article-title":"Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians","volume":"329","author":"Lillioja","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.07.054_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2337\/diacare.23.2.171","article-title":"Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers","volume":"23","author":"Yeni-Komshian","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2016.07.054_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.amjcard.2005.03.085","article-title":"Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?","volume":"96","author":"McLaughlin","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2016.07.054_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-013-0461-2","article-title":"Evaluation of fasting plasma insulin concentration as an estimate of insulin action in nondiabetic individuals: comparison with the homeostasis model assessment of insulin resistance (HOMA-IR)","volume":"51","author":"Abbasi","year":"2014","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.amjcard.2016.07.054_bib11","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/ATVBAHA.111.224790","article-title":"Wanted!: a standardized measurement of plasma insulin concentration","volume":"31","author":"Reaven","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2016.07.054_bib12","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.2337\/diacare.28.10.2388","article-title":"Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study","volume":"28","author":"Novoa","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2016.07.054_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/dc07-1574","article-title":"Isolated impaired fasting glucose and peripheral insulin sensitivity: not a simple relationship","volume":"31","author":"Kim","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2016.07.054_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jacc.2014.10.053","article-title":"Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL","volume":"65","author":"Kohli","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.07.054_bib15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0735-1097(02)02051-X","article-title":"Relationship between obesity, insulin resistance, and coronary heart disease risk","volume":"40","author":"Abbasi","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.07.054_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.1992.tb00494.x","article-title":"Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations","volume":"231","author":"Laws","year":"1992","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.amjcard.2016.07.054_bib17","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.07.054_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1559-4572.2008.07967.x","article-title":"High-dose atorvastatin after stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators","volume":"3","author":"Karam","year":"2008","journal-title":"J\u00a0Cardiometab Syndr"},{"issue":"Suppl","key":"10.1016\/j.amjcard.2016.07.054_bib19","first-page":"S4","article-title":"Standards of medical care in diabetes\u20132015: summary of revisions","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2016.07.054_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.103.3.357","article-title":"Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study","volume":"103","author":"Freeman","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.07.054_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.07.054_bib22","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.amjcard.2014.02.011","article-title":"Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study)","volume":"113","author":"Ong","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2016.07.054_bib23","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00125-015-3528-5","article-title":"Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort","volume":"58","author":"Cederberg","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.amjcard.2016.07.054_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2016.07.054_bib25","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jama.2015.1206","article-title":"Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus","volume":"313","author":"Besseling","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2016.07.054_bib26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4065\/83.4.470","article-title":"Effects of niacin on glucose control in patients with dyslipidemia","volume":"83","author":"Goldberg","year":"2008","journal-title":"Mayo Clin Proc"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916313248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916313248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:48:17Z","timestamp":1655858897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914916313248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0002914916313248"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.07.054","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.07.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}